Artificial Intelligence Animal Health Market Summary
According to Market Research Future Reports analysis, the Artificial Intelligence In Animal Health Market size was valued at USD 1105.08 Billion in 2024. The market is projected to grow from USD 1154.5 Billion in 2025 to USD 1788.12 Billion by 2035, registering a CAGR of 4.47% during the forecast 2025–2035. North America leads the market, accounting for 45% of the global revenue in 2024.
Growing demand for advanced veterinary diagnostics and efficient livestock management is a key growth driver, as artificial intelligence enhances disease detection, predictive care, and operational efficiency, supporting improved animal health outcomes and accelerating adoption of data-driven veterinary solutions globally.
- According to the World Health Organization (WHO), over 60% of emerging infectious diseases are zoonotic, highlighting strong demand for advanced monitoring tools, while the Food and Agriculture Organization estimates livestock supports livelihoods of 1.3 billion people, reinforcing need for AI-driven animal health solutions.
Key Market Trends & Highlights
The Artificial Intelligence in Animal Health Market is poised for substantial growth driven by technological advancements and increasing demand for animal health solutions.
- North America leads with 45% market share in 2024, driven by advanced veterinary infrastructure and strong AI technology adoption.
- Companion animals segment holds 47% share in 2024, fueled by increasing global pet ownership and rising healthcare spending.
- Rising zoonotic disease burden, with over 60% infections animal-origin, is significantly driving AI adoption in veterinary diagnostics and monitoring systems.
- Machine learning dominates with 44% share in 2024, supported by increasing demand for scalable data analytics in animal healthcare.
Market Size & Forecast
| 2024 Market Size | 1105.08 (USD Billion) |
| 2035 Market Size | 1788.12 (USD Billion) |
| CAGR (2025 - 2035) | 4.47% |
Major Players
Companies such as Zoetis (US), Merck Animal Health (US), Boehringer Ingelheim (DE), Elanco Animal Health (US), Dechra Pharmaceuticals (GB), VetCT (GB), PetPace (US), Heska Corporation (US), IDEXX Laboratories (US) are some of the major participants in the global market.